T1	Participants 130 150	postmenopausal women
T2	Participants 532 552	postmenopausal women
T3	Participants 562 653	Seventy-five postmenopausal women symptomatic for urogenital atrophy and sexual dysfunction
T4	Participants 1799 1832	symptomatic postmenopausal women.
